Back to SEI Investments Co. SEI Investments Co.

HBIO

8 quarters

Position history for SEI Investments Co.SEI Investments Co.'s holdings in Harvard Bioscience, Inc.

No. SEI Investments exited its HBIO (Harvard Bioscience) position in Q2 2025. Its Q1 2025 13F listed 22,268 shares worth $12,604. SEI Investments first reported HBIO in Q2 2021 and held it in 6 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$451,000

Total Shares Change

-54,187

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$4.40
0
2025-Q1
Unchanged
22,268
0.0%
$12,6040.0%$5.70
0
2024-Q4
New
22,268
-
$46,9850.0%$21.10
28
2022-Q2
Exited
0
-100.0%
$00.0%$36.00
0
2022-Q1
Decreased
74,848
-21.8%
$465,0000.0%$62.10
0
2021-Q4
Increased
95,723
+11.4%
$675,0000.0%$70.50
27
2021-Q3
Increased
85,886
+58.5%
$599,0000.0%$69.80
35
2021-Q2
New
54,187
-
$451,0000.0%$83.30
33

Other major holders of HBIO: Royce & Associates LP, Dimensional Fund Advisors LP, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used